Clinical Trial Update: Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and immunogenicity of an HPV vaccine in HIV-infected females has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus, Papillomavirus Vaccines | Phase 4 | Status: COMPLETED | Results posted: 2019-07-24